These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 15708437

  • 21. N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease.
    Gironès X, Guimerà A, Cruz-Sánchez CZ, Ortega A, Sasaki N, Makita Z, Lafuente JV, Kalaria R, Cruz-Sánchez FF.
    Free Radic Biol Med; 2004 May 15; 36(10):1241-7. PubMed ID: 15110389
    [Abstract] [Full Text] [Related]

  • 22. Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer's disease.
    Lau DH, Hogseth M, Phillips EC, O'Neill MJ, Pooler AM, Noble W, Hanger DP.
    Acta Neuropathol Commun; 2016 May 18; 4(1):49. PubMed ID: 27193083
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons.
    Chalmers KA, Love S.
    J Neuropathol Exp Neurol; 2007 Feb 18; 66(2):158-67. PubMed ID: 17279001
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
    Pei JJ, Sjögren M, Winblad B.
    Curr Opin Psychiatry; 2008 Nov 18; 21(6):555-61. PubMed ID: 18852562
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. p59fyn in rat brain is localized in developing axonal tracts and subpopulations of adult neurons and glia.
    Bare DJ, Lauder JM, Wilkie MB, Maness PF.
    Oncogene; 1993 Jun 18; 8(6):1429-36. PubMed ID: 8502471
    [Abstract] [Full Text] [Related]

  • 33. Phosphorylation of tau by fyn: implications for Alzheimer's disease.
    Lee G, Thangavel R, Sharma VM, Litersky JM, Bhaskar K, Fang SM, Do LH, Andreadis A, Van Hoesen G, Ksiezak-Reding H.
    J Neurosci; 2004 Mar 03; 24(9):2304-12. PubMed ID: 14999081
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease.
    Snow AD, Nochlin D, Sekiguichi R, Carlson SS.
    Exp Neurol; 1996 Apr 03; 138(2):305-17. PubMed ID: 8620929
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Zinc transporter mRNA levels in Alzheimer's disease postmortem brain.
    Beyer N, Coulson DT, Heggarty S, Ravid R, Hellemans J, Irvine GB, Johnston JA.
    J Alzheimers Dis; 2012 Apr 03; 29(4):863-73. PubMed ID: 22349685
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Regulatory region genetic variation is associated with FYN expression in Alzheimer's disease.
    Zahratka JA, Shao Y, Shaw M, Todd K, Formica SV, Khrestian M, Montine T, Leverenz JB, Bekris LM.
    Neurobiol Aging; 2017 Mar 03; 51():43-53. PubMed ID: 28033507
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.